Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NIRAPARIB Cause Blood potassium decreased? 259 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 259 reports of Blood potassium decreased have been filed in association with NIRAPARIB (ZEJULA). This represents 1.2% of all adverse event reports for NIRAPARIB.

259
Reports of Blood potassium decreased with NIRAPARIB
1.2%
of all NIRAPARIB reports
9
Deaths
95
Hospitalizations

How Dangerous Is Blood potassium decreased From NIRAPARIB?

Of the 259 reports, 9 (3.5%) resulted in death, 95 (36.7%) required hospitalization, and 16 (6.2%) were considered life-threatening.

Is Blood potassium decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NIRAPARIB. However, 259 reports have been filed with the FAERS database.

What Other Side Effects Does NIRAPARIB Cause?

Nausea (5,794) Fatigue (5,240) Constipation (4,128) Platelet count decreased (4,102) Insomnia (2,861) Blood pressure increased (2,464) Headache (2,383) Off label use (2,213) Vomiting (2,029) Carbohydrate antigen 125 increased (1,868)

What Other Drugs Cause Blood potassium decreased?

LENALIDOMIDE (1,991) ADALIMUMAB (1,274) TREPROSTINIL (461) FUROSEMIDE (419) MIFEPRISTONE (411) PREDNISONE (399) SACUBITRIL\VALSARTAN (368) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (336) MACITENTAN (321) AMBRISENTAN (282)

Which NIRAPARIB Alternatives Have Lower Blood potassium decreased Risk?

NIRAPARIB vs NIRMATRELVIR\RITONAVIR NIRAPARIB vs NIROGACESTAT NIRAPARIB vs NIROGACESTAT HYDROBROMIDE NIRAPARIB vs NIRSEVIMAB NIRAPARIB vs NIRSEVIMAB-ALIP

Related Pages

NIRAPARIB Full Profile All Blood potassium decreased Reports All Drugs Causing Blood potassium decreased NIRAPARIB Demographics